CY1116335T1 - PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE - Google Patents

PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE

Info

Publication number
CY1116335T1
CY1116335T1 CY20151100301T CY151100301T CY1116335T1 CY 1116335 T1 CY1116335 T1 CY 1116335T1 CY 20151100301 T CY20151100301 T CY 20151100301T CY 151100301 T CY151100301 T CY 151100301T CY 1116335 T1 CY1116335 T1 CY 1116335T1
Authority
CY
Cyprus
Prior art keywords
chloropyridin
yloxy
carboxamide
ethoxy
amino
Prior art date
Application number
CY20151100301T
Other languages
Greek (el)
Inventor
Dilbir S Bindra
Madhushree Yeshwant Gokhale
Cletus John Nunes
Victor W Rosso
Gretchen M Schroeder
Ajit B Thakur
Xiaotian Yin
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11717917.6A external-priority patent/EP2563763B1/en
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of CY1116335T1 publication Critical patent/CY1116335T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αποκαλύπτονται άλατα και κρυσταλλικές μορφές του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου και των αλάτων εξ αυτού. Επίσης αποκαλύπτονται μια τουλάχιστον φαρμακευτική σύνθεση που περιλαμβάνει μια τουλάχιστον κρυσταλλική μορφή του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου, μια τουλάχιστον μέθοδος χρήσης μιας τουλάχιστον κρυσταλλικής μορφής του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου για την αγωγή του καρκίνου και/ή άλλων υπερπλαστικών παθήσεων, και διεργασίες για την παρασκευή των κρυσταλλικών μορφών του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου και των αλάτων εξ αυτού.Salts and crystalline forms of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2-oxo-1,2- dihydropyridine-3-carboxamide and the salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2 -oxo-1,2-dihydropyridin-3-carboxamide, at least one method of using at least one crystalline form of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy- 1- (4-fluorophenyl) -2-oxo-1,2-dihydropyridin-3-carboxamide for the treatment of cancer and / or other hyperplastic diseases, and processes for the preparation of crystalline forms of N- (4- (2- amino-3 -chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2-oxo-1,2-dihydropyridin-3-carboxamide and the salts thereof.

CY20151100301T 2010-04-30 2015-03-26 PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE CY1116335T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32971010A 2010-04-30 2010-04-30
EP11717917.6A EP2563763B1 (en) 2010-04-30 2011-04-29 Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide

Publications (1)

Publication Number Publication Date
CY1116335T1 true CY1116335T1 (en) 2017-02-08

Family

ID=58457985

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100301T CY1116335T1 (en) 2010-04-30 2015-03-26 PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE

Country Status (1)

Country Link
CY (1) CY1116335T1 (en)

Similar Documents

Publication Publication Date Title
CY1125613T1 (en) 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4- IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS
CY1121418T1 (en) HEPATITIS VIRUS INHIBITORS C
CY1120318T1 (en) Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients
CY1123810T1 (en) TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA
CY1121625T1 (en) PRMT5 INHIBITORS AND USES THEREOF
CY1119490T1 (en) PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT
CY1123627T1 (en) DIHYDROIMIDAZOPYZINONE DERIVATIVES USEFUL IN THE THERAPEUTIC TREATMENT OF CANCER
CY1118678T1 (en) CHLORO-PYRAZINE CARBOXAMIDE PRODUCERS USEFUL FOR THE THERAPEUTIC TREATMENT OF DISEASES CONSIDERED BY INadequate hydration
CY1119004T1 (en) DIAHYDROPYRIDONE P1 AS AN OPTIONAL CHIA
EA201490647A1 (en) DERIVATIVES OF BENZOTHIAZOL-6-LUCUS ACID AND THEIR APPLICATION FOR THE TREATMENT OF HIV INFECTION
MX2015013396A (en) Quinolines derivatives as novel anticancer agents.
MD3313850T2 (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
EA201500298A1 (en) ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES
PH12019501896A1 (en) Therapeutic dendrimers
BR112014007163A2 (en) n-methyl-2 [3 ((e) -2-pyridin-2-yl-vinyl) -1h-indazol-6-ylsulfanyl] -benzamide pharmaceutical compositions
MX2013008431A (en) Mineralocorticoid receptor antagonists.
CY1114140T1 (en) 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER
CY1116775T1 (en) Pyrimidone derivatives as inhibitors of viral transglutaminase
CY1124251T1 (en) CARBOXAMIDE DERIVATIVES
CY1123494T1 (en) ETEPOAPYLO-KAPBOXAMIDIOY COMPOUNDS AS THS RIPK2 ANASTOLES
EA201300946A1 (en) ASYMMETRIC UREA AND THEIR MEDICAL APPLICATION
WO2013040227A3 (en) Therapeutic compounds
TW201613864A (en) Novel compounds
TR201900148T4 (en) 2,4 diamino-quinoline substituted as novel agents against cancer.
CY1122077T1 (en) NEW CYCLED PHENOXYACETAMIDIES